ArticleBritish journal of cancer2023

A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.

Daphne Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.